Some of the most prominent institutions in Berlin and beyond are working together on ImmunoPreCept. When combined, unmatched knowledge in clinical research, immunology, molecular biology, systems medicine, and data science creates a potent environment for ground-breaking research.
Some of the most prominent institutions in Berlin are working together within the ImmunoPreCept Excellence Cluster. Among the principal partners are Charité – Universitätsmedizin Berlin, the Max Delbrück Center for Molecular Medicine (MDC), Freie Universität Berlin, Humboldt-Universität zu Berlin, the Berlin Institute of Health (BIH), the German Rheumatism Research Center (DRFZ), and the Max Planck Institute for Molecular Genetics. Their combined expertise in immunology, molecular biology, systems of medicine and data science creates an exceptional environment for pioneering research into how the immune system preserves health.
In addition to these Berlin based institutions, ImmunoPreCept collaborates with prominent international partners, including the NOVA Institute for Medical Systems Biology (Portugal) and the Kennedy Institute of Rheumatology at the University of Oxford (UK). These global partnerships enrich the cluster’s research landscape by introducing complementary perspectives and advanced methodologies that strengthen efforts to understand early immune dysregulation and advance preventive medicine.
Work within interdisciplinary teams across multiple institutes.
Explore opportunities for interactions with ImmunoPreCept research and researchers.